Back to HALO
BlackRock Finance, Inc. → HALO
BlackRock Finance, Inc. HALO Position History
Halozyme Therapeutics, Inc. • Healthcare
Quarters held
18
Latest value
$10.4M
Q2 2024
Peak value
$545.3M
First seen
Q2 2024
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2024 | $14M |
| Q2 2024 | $22K |
| Q2 2024 | $900K |
| Q2 2024 | $26.1M |
| Q2 2024 | $53.7M |
| Q2 2024 | $545.3M |
| Q2 2024 | $236.6M |
| Q2 2024 | $569K |
| Q2 2024 | $1.4M |
| Q2 2024 | $7.1M |
| Q2 2024 | $3.6M |
| Q2 2024 | $49K |
| Q2 2024 | $21.1M |
| Q2 2024 | $106K |
| Q2 2024 | $97K |
| Q2 2024 | $1.4M |
| Q2 2024 | $61K |
| Q2 2024 | $10.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2024 | $10.4M | 198.5K | — | — |
| Q2 2024 | $61K | 1.2K | — | — |
| Q2 2024 | $1.4M | 27.5K | — | — |
| Q2 2024 | $97K | 1.8K | — | — |
| Q2 2024 | $106K | 2.0K | — | — |
| Q2 2024 | $21.1M | 402.7K | — | — |
| Q2 2024 | $49K | 927 | — | — |
| Q2 2024 | $3.6M | 68.0K | — | — |
| Q2 2024 | $7.1M | 136.1K | — | — |
| Q2 2024 | $1.4M | 26.5K | — | — |
| Q2 2024 | $569K | 10.9K | — | — |
| Q2 2024 | $236.6M | 4.52M | — | — |
| Q2 2024 | $545.3M | 10.41M | — | — |
| Q2 2024 | $53.7M | 1.03M | — | — |
| Q2 2024 | $26.1M | 499.1K | — | — |
| Q2 2024 | $900K | 17.2K | — | — |
| Q2 2024 | $22K | 427 | — | — |
| Q2 2024 | $14M | 267.5K | — | — |
Other funds holding HALO
$405.4M
$405.4M
$319.1M
$251.9M
$176.7M
$148.6M